Diabetic Nephropathy Type 2: Clinical Trials

6 trials for Diabetic Nephropathy Type 2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown, 1 not yet recruiting, 1 recruiting. 6 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable6Completed 2, Unknown 2, Not yet recruiting 1, Recruiting 1

Follow Diabetic Nephropathy Type 2: new trials by email Literature Review of Diabetic Nephropathy Type 2 trials Research Report on Diabetic Nephropathy Type 2

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Research on Innovative Traditional Chinese Medicine Diagnosis and Treatment Technologies for Diabetic Nephropathy Driven by Multi-Omics and Artificial Intelligence
Jiajian Yishen Xiaozheng Qufeng Granules - Diabetic Nephropathy Type 2, Chronic Renal Failure/ Kidney Disease
Not applicableNot yet recruitingJiazhen Yin1982026-03-122026-03-10
Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes
Polygenic Risk Score - Diabetes Mellitus, Type 2, Cardiovascular Diseases
Not applicableRecruitingOptithera27142024-08-232024-09-19
Effect of Exercise Therapy on Type II Diabetic Neuropathic Patients
Experimental group 1 :Ball training, Experimental group 2 :Frenkel Exercises, Control Group - Diabetic Nephropathy Type 2
Not applicableCompletedDr. Sobia Hasan902024-05-052024-12-31
Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.
Dorzagliatin, Gliclazide - Diabetic Nephropathy Type 2
Not applicableUnknownYan Bi1062024-02-202024-01-24
Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy.
Fasting mimicking diet Prolon, Food supplement Endocalyx, Placebo - Diabetic Nephropathy Type 2, Albuminuria
Not applicableCompletedLeiden University Medical Center562018-05-032021-02-18
Extracorporeal Low-intensity Shockwave in Diabetic Nephropathy
Extracorporeal low-intensity shockwave - Diabetic Nephropathy Type 2
Not applicableUnknownChang Gung Memorial Hospital602017-07-012018-02-26

Narrower conditions

Diabetes Mellitus, Type 2 (2)  ·  Diabetic Nephropathies (2)  ·  Albuminuria (1)  ·  Cardiovascular Diseases (1)  ·  Diabetes Mellitus (1)  ·  Diabetic Neuropathies (1)  ·  Genetic Risk Score (1)  ·  Glucose Metabolism Disorders (1)  ·  Kidney Diseases (1)  ·  Proteinuria (1)

Broader conditions

Endocrine System Diseases (4)  ·  Diabetes Complications (3)  ·  Diabetes Mellitus (3)  ·  Metabolic Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Glucose Metabolism Disorders (2)  ·  Male Urogenital Diseases (2)  ·  Signs and Symptoms (2)  ·  Urination Disorders (2)  ·  Urogenital Diseases (2)  ·  Urologic Diseases (2)  ·  Urological Manifestations (2)

Interventions

Control Groups (1)  ·  Dorzagliatin (1)  ·  Gestyl (1)  ·  Gliclazide (1)

Sponsors

Chang Gung Memorial Hospital (1)  ·  Dr. Sobia Hasan (1)  ·  Jiazhen Yin (1)  ·  Leiden University Medical Center (1)  ·  Optithera (1)  ·  Yan Bi (1)

Countries

Canada (1)  ·  China (1)  ·  Netherlands (1)  ·  Pakistan (1)  ·  Taiwan (1)

Top investigators

Aftab Ahmed Mirza Baig, PhD (1)  ·  Pavel Hamet, MD, PhD (1)  ·  Sobia Hasan, PhD* (1)  ·  Ton J. Rabelink, Prof. (1)

Results publications

PMID 32848436, PMID 33131308, PMID 34940288, PMID 38600065